PCI PHARMA SERVICES — Ezetimibe Importer Profile
Pharmaceutical Importer · #2 buyer for Ezetimibe · $1.1M import value · 35 shipments · UNITED STATES · DGFT Verified
PCI PHARMA SERVICES is the #2 importer of Ezetimibe from India with $1.1M in import value and 35 verified shipments. PCI PHARMA SERVICES holds a 0.7% market share in Ezetimibe imports based in UNITED STATES. The company sources from 1 verified supplier across 9 formulations shipped to 1 country.
PCI PHARMA SERVICES — Ezetimibe Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ezetimibe to PCI PHARMA SERVICES?
Verified from 35 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PIRAMAL PHARMA LIMITED | $1.1M | 35 | 100.0% |
PCI PHARMA SERVICES sources Ezetimibe from 1 verified Indian supplier based on 35 customs records. The primary supplier is PIRAMAL PHARMA LIMITED accounting for 100.0% of imports.
How Does PCI PHARMA SERVICES Compare to Nearest Ezetimibe Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | ASCEND LABORATORIES LLC | UNITED STATES | $5.0M | 100 | $50.0K |
| 7 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $3.4M | 99 | $34.2K |
| 2 | PCI PHARMA SERVICES ★ | UNITED STATES | $1.8M | 35 | $50.0K |
| 11 | MICRO LABS GMBH | GERMANY | $1.6M | 33 | $50.0K |
| 9 | ACCORD HEALTHCARE PTE LTD | SINGAPORE | $1.5M | 30 | $50.0K |
PCI PHARMA SERVICES ranks #2 among 466 Ezetimibe importers from India. Average shipment value of $50.0K compared to the market average of $112.5K. The closest competitors by value are ASCEND LABORATORIES LLC and YUSEN LOGISTICS BENELUX BELGIUM.
Where Does PCI PHARMA SERVICES Import Ezetimibe To?
Destination countries from 35 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 35 | 100.0% |
PCI PHARMA SERVICES imports Ezetimibe to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.1M.
What Ezetimibe Formulations Does PCI PHARMA SERVICES Import?
| Formulation | Value | Shipments |
|---|---|---|
| (431304001) BEMPEDOIC ACID AND EZETIMIBE FIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK | $404.6K | 9 |
| (431304001) BEMPEDOIC ACID AND EZETIMIBEFIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK PACK | $243.5K | 11 |
| 431304001 Bempedoic Acid and EzetimibeFixed Dose Combination Tablets, Bempedoic180mg+Ez10mg TabsFDCBulk Pack | $121.4K | 3 |
| 431304001 Bempedoic Acid and Ezetimibe | $76.8K | 3 |
| (431304001) Bempedoic Acid and Ezetimibe | $75.8K | 2 |
| 431304001 Bempedoic Acid and EzetimibeFixed Dose Combination Tablets Bempedoic180mg+Ez10mg TabsFDCBulk Pack | $72.4K | 2 |
| (401304009) BEMPEDOIC ACID AND EZETIMIBE | $50.0K | 1 |
| (431304001) BEMPEDOIC ACID AND EZETIMIBE FIXED DOSE COMBINATION TABLETS, Bempedoic180mg+Ez10mg Tabs(FDC)Bulk | $50.0K | 1 |
| (431304001) BEMPEDOIC ACID AND EZETIMIBEFIXED DOSE COMBINATION TABLETS, BEMPEDOIC180MG+EZ10MG TABS(FDC)BULK PACKNOS | $29.4K | 3 |
PCI PHARMA SERVICES imports 9 distinct Ezetimibe formulations from India. The top formulation is (431304001) BEMPEDOIC ACID AND EZETIMIBE FIXED DOSE COMBINAT with 9 shipments worth $404.6K.
Regulatory Requirements: Importing Ezetimibe into United States
What PCI PHARMA SERVICES and other importers must comply with to import Ezetimibe from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ezetimibe
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ezetimibe from India and How Much Does PCI PHARMA SERVICES Import?
India exported $52.4M worth of Ezetimibe through 5,033 shipments from 169 suppliers to 85 countries, serving 466 buyers globally. PCI PHARMA SERVICES imports $1.1M of this total, accounting for 0.7% of India's Ezetimibe exports with 35 shipments from UNITED STATES. This is verified from 35 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for PCI PHARMA SERVICES's Ezetimibe Imports?
PCI PHARMA SERVICES's average Ezetimibe order value is $32.1K per consignment, based on 35 shipments totaling $1.1M. PCI PHARMA SERVICES is based in UNITED STATES and ranks #2 among all Ezetimibe importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ezetimibe to PCI PHARMA SERVICES?
PCI PHARMA SERVICES sources Ezetimibe from 1 verified Indian supplier: PIRAMAL PHARMA LIMITED ($1.1M, 100.0%). This is based on 35 customs records.
How Does PCI PHARMA SERVICES Compare to Other Ezetimibe Importers?
PCI PHARMA SERVICES ranks #2 among 466 Ezetimibe importers from India with a 0.7% market share. The top 3 importers are BGP PRODUCTS GMBH ($16.4M), DAIICHI SANKYO EUROPE GMBH ($10.1M), ASCEND LABORATORIES,LLC ($6.7M). PCI PHARMA SERVICES processed 35 shipments from UNITED STATES.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ezetimibe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ezetimibe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PCI PHARMA SERVICES matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PCI PHARMA SERVICES's capped import value divided by total capped export value for Ezetimibe across all Indian exporters.
- 5.Verified Records: This page is backed by 35 individual customs records matching PCI PHARMA SERVICES importing Ezetimibe, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 85+ countries, 466+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ezetimibe Import Data for PCI PHARMA SERVICES
Access order-level details, pricing data, supplier connections, and competitive analysis for PCI PHARMA SERVICES's Ezetimibe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PCI PHARMA SERVICES
Company Profile
Multiple products · $0 total trade · Multiple categories
PCI PHARMA SERVICES × Ezetimibe
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PCI PHARMA SERVICES.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ezetimibe. For current order-level data, contact TransData Nexus.